Exploring the Roots
of Lung Disease in Down Syndrome
CONDITIONS SUCH AS underdeveloped lungs, known as
pulmonary hypoplasia, and high blood pressure in the arteries of the
lungs, known as pulmonary arterial hypertension (PAH), occur in
approximately 20 percent of children born with Down syndrome,
according to data collected by Csaba Galambos, M.D., Ph.D., a
pediatric pathologist in the Children's Hospital Colorado Department
of Pathology and Laboratory Medicine and Associate Professor of
Pathology at the University of Colorado School of Medicine.
A group of researchers led by Dr. Galambos is exploring, for
the first time, why individuals with Down syndrome are more
susceptible to these conditions. His lab has hypothesized that
central to the development of pulmonary hypoplasia and PAH is the
suppression of the process that prompts the growth of new blood
vessels, a chain of events called angiogenesis. Their discoveries
could lead not only to therapies for pulmonary disease in individuals
with Down syndrome, but also to treatments that may improve lung
development and function in all patients.
A DOUBLE-EDGED SWORD
Dr. Galambos' fascination with angiogenesis began years ago, when
COULD FACTORS THAT
PREVENT THE FORMATION
OF NEW BLOOD VESSELS
IN THE LUNGS ACCOUNT
FOR THE HIGH PREVALENCE
OF PULMONARY DISEASE
IN INFANTS WITH DOWN
SYNDROME? THE ANSWER
COULD HAVE FAR-REACHING
IMPLICATIONS THAT EXTEND
BEYOND LUNG HEALTH.
GLOBALDOWNSYNDROME.ORG
9